Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats
about
Nitric oxide and peroxynitrite in health and diseasePeroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in ratsNeuronal injury from cardiac arrest: aging years in minutes.Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats.S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats.Blocking a vicious cycle nNOS/peroxynitrite/AMPK by S-nitrosoglutathione: implication for stroke therapy.P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitriteThe inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental strokeTargeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI.Modulation of myocardial contraction by peroxynitritePostischemic hyperoxia reduces hippocampal pyruvate dehydrogenase activityReperfusion activates metalloproteinases that contribute to neurovascular injuryINO-4885 [5,10,15,20-tetra[N-(benzyl-4'-carboxylate)-2-pyridinium]-21H,23H-porphine iron(III) chloride], a peroxynitrite decomposition catalyst, protects the heart against reperfusion injury in mice.Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic stroke.Neuroprotective Potential of Peroxisome Proliferator Activated Receptor- α Agonist in Cognitive Impairment in Parkinson's Disease: Behavioral, Biochemical, and PBPK Profile.One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke.Astrocytes: targets for neuroprotection in stroke.Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.Therapeutic potential of peroxynitrite decomposition catalysts: a patent review.Ferulic acid inhibits nitric oxide-induced apoptosis by enhancing GABA(B1) receptor expression in transient focal cerebral ischemia in ratsRole of matrix metalloproteinase activity in the neurovascular protective effects of Angiotensin antagonism.Peroxynitrite decomposition with FeTMPyP improves plasma-induced vascular dysfunction and infarction during mild but not severe hyperglycemic stroke.Edaravone offers neuroprotection in a diabetic stroke model via inhibition of endoplasmic reticulum stress.Systemic administration of Zn2+ during the reperfusion phase of transient cerebral ischaemia protects rat hippocampus against iron-catalysed postischaemic injury.Peroxynitrite is Involved in the Apoptotic Death of Cultured Cerebellar Granule Neurons Induced by Staurosporine, but not by Potassium Deprivation.The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review.Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway.Arctic ground squirrel resist peroxynitrite-mediated cell death in response to oxygen glucose deprivation.Neuroprotective effects of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), an antioxidant in middle cerebral artery occlusion induced focal cerebral ischemia in rats.Peroxynitrite Decomposition Catalyst Reduces Delayed Thrombolysis-induced Hemorrhagic Transformation in Ischemia-reperfused Rat Brains.Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia.Unconventional neuroprotection against Ca2+ -dependent insults by metalloporphyrin catalytic antioxidants.PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model.Augmentation of endoplasmic reticulum stress in cerebral ischemia/reperfusion injury associated with comorbid type 2 diabetes.Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery.Quantification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin in rodent brain by UHPLC/ESI-Q-TOF-MS/MS after intra-nasal administration of curcuminoids loaded PNIPAM nanoparticlesA comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental strokeIsolation, characterization, and quantification of curcuminoids and their comparative effects in cerebral ischemia
P2860
Q24645400-787B5DB0-2072-41CF-8BED-57C96E383803Q24807077-0E560442-DF03-487E-8DD7-0401CA465CDAQ34116168-DBC4E1A1-7E3A-4C3C-93CD-5C8E4E180AD3Q34281028-93B10956-D9AA-48F7-A06D-6183E1168F6FQ35172025-BBC55629-103B-4EFD-B140-C371FC513563Q35691264-FAEE0DBB-FC66-482C-A6CF-B2D6A39D21FFQ36171940-54377C70-F9C7-45A0-960A-A81719BDEDEAQ36347434-568B2ADA-BA89-4DFF-A213-76FB45C5B437Q36386519-9AAD2D00-8210-4563-AFE2-094012BFE1BBQ36461910-8956C68B-722C-4A9A-AC0D-10A5917F89D9Q36944433-96142871-A296-488F-8708-83407D584760Q36986393-8F368355-F936-45BD-BEC4-474E127E0751Q37145846-7CCF6DFF-3F14-45A9-A1B6-0B008CF6F863Q37440577-30F54DA0-E3CF-4C11-AA71-C9CDC58A7F75Q37622376-AAA24FC5-CB22-4170-A2AC-52D88B6918D5Q37668019-60F5AFC1-73B2-4006-B983-578D4A415DBAQ37869174-C1D25E25-DF45-448D-98D8-39F916F8417EQ38030379-115F5517-B603-4F58-BB0A-459341618F3EQ38053032-B4850BFB-3E02-427B-AED0-C60540EF371DQ38190431-E348D424-6B7E-4A70-BA7A-F3CF3E4C3CD5Q38313367-B42B2C93-A95A-4C52-9D9D-02148F77C7CFQ39155194-7F03D746-257E-411B-8825-F3A3BD2750A6Q41967249-27C70BE0-0F86-448B-A4BF-664BAF179CA7Q42183840-C50916DF-9F8B-4E94-928E-90CA05D5ED36Q45846630-5D3C99D4-7EF1-4879-B369-328BF7E9CA4CQ46607907-60F57B79-BFF6-46CB-8476-C2F3E571A119Q46619662-ECAD083F-CB39-4992-87EF-0A00EBC08558Q47854993-EA2FC3A0-0B5F-4F69-AA59-C338A1A29847Q47897171-B6053834-3B54-459B-991E-830C47D17B0BQ48091052-031F6791-FCB6-43F5-821A-73CF1DCD6904Q48164696-9055D6C9-1466-4267-AE78-FD4EF851673EQ48166886-B6BFDB4E-E7EC-4FE0-B04C-D1BEE4969383Q48201155-6FB606F8-BD7E-48B3-90BE-D1DB1299116BQ48452275-D54C86DC-3935-4918-BF29-211D63EA3747Q48477773-FDA3CC87-A6DC-4131-AA2C-8F5DC97A90A6Q48833072-FD7D8424-5A67-42C9-9F36-D82F36EC8811Q54982616-A11533F6-6660-4045-ABEF-FD8B43BC220FQ57342581-8DF2EC3C-8706-4A8C-B156-6EA2B3789C02Q57347039-2EAB0BAF-28B8-48EA-9E37-C118842221B9Q57369528-D836E000-A487-4A51-B6E9-74DBDF075802
P2860
Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Neuroprotective efficacy and t ...... ocal cerebral ischemia in rats
@en
type
label
Neuroprotective efficacy and t ...... ocal cerebral ischemia in rats
@en
prefLabel
Neuroprotective efficacy and t ...... ocal cerebral ischemia in rats
@en
P2093
P2860
P356
P1476
Neuroprotective efficacy and t ...... ocal cerebral ischemia in rats
@en
P2093
Chaman Lal Kaul
Meenakshisundaram Thiyagarajan
Shyam Sundar Sharma
P2860
P304
P356
10.1038/SJ.BJP.0705811
P407
P577
2004-06-14T00:00:00Z